Self-administered Moxibustion for Long COVID: The Moxafrica 100 Day Moxa Challenge

This article reports on the methodology and results of a small research project that aimed to investigate whether 100 days of self-administered direct moxibustion had meaningful outcomes for patients suffering from Long COVID. Although firm conclusions cannot be made due to the limitations of the evidence, the early results were encouraging, and concur with research previously conducted by Moxafrica on moxibustion for drug resistant tuberculosis. Based on these positive results, Moxafrica has started a remote treatment programme to provide free equipment and instruction on treatment to people suffering from Long Covid anywhere in the world - especially those living in countries where there is no other medical treatment available.